VEGFA and neoplasm: Specifically, these studies are investigating the role of immunotherapy in combination with poly(ADP-ribose) polymerase (PARP) inhibitors that can enhance the infiltration of cytotoxic T lymphocytes and increase tumor antigens, need further investigation or in combination with and vascular endothelial growth factor (VEGF) inhibitors.